Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | |
| Gross profit | 0.0 | 0.0 | 0.0 | |
| Research and development | 88.2 | 67.2 | 29.2 | |
| General and administrative | 30.4 | 22.9 | 6.8 | |
| EBIT | -118.5 | -90.1 | -36.0 | |
| Pre-tax income | -116.3 | -89.8 | -35.8 | |
| Income taxes | 0.0 | 0.0 | 0.0 | |
| Tax rate | 0.0% | 0.0% | 0.0% | |
| Net income | -116.3 | -89.8 | -35.8 | |
| |
| Diluted EPS | ($2.64) | ($2.06) | ($5.28) | |
| Shares outstanding (diluted) | 44.1 | 43.6 | 6.8 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|